Michael Jay, Ph.D.
Dr. Jay is a Founder of Arcato and serves as Chief Technology Officer. Dr. Jay is the Fred Eshelman Chair and distinguished professor of molecular pharmaceutics at the University of North Carolina at Chapel Hill, and is an expert on drug delivery and formulations. Dr. Jay joined the UNC Eshelman School of Pharmacy in 2008 after a 27 year career at the University of Kentucky College of Pharmacy.
Dr. Jay’s research projects are centered on the interface between the pharmaceutical and nuclear sciences, involving the application of pharmaceutical approaches to solve problems related to nuclear imaging and therapy, and the use of radioanalytical approaches to solve problems encountered in the development of novel formulations and drug delivery systems. Dr. Jay is also a serial entrepreneur, having co-founded four biotechnology companies. He has authored hundreds of peer-reviewed publications, and sits on the editorial boards of several scientific journals. In October 2010, Dr. Jay was principal investigator on a $6.6 million federal contract awarded to the UNC Eshelman School of Pharmacy to research a medication that can help clear radioactive elements from the body. Dr. Jay co-invented the patented technology behind the OraWax™ formulation. Dr. Jay received his Ph.D. in Pharmaceutical Sciences from the University of Kentucky, and his B.S. in Pharmacy from the State University of New York at Buffalo.